Notice2021-15226
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 19, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 135 (Monday, July 19, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 135 (Monday, July 19, 2021)]
[Notices]
[Pages 38096-38097]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-15226]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-21DC]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled National Syringe Services Program (SSP)
Evaluation to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on February
25, 2021 to obtain comments from the public and affected agencies. CDC
received three public comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open
[[Page 38097]]
for Public Comments'' or by using the search function. Direct written
comments and/or suggestions regarding the items contained in this
notice to the Attention: CDC Desk Officer, Office of Management and
Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Syringe Services Program Evaluation--New--National Center
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The primary purpose of the National Syringe Services Program (SSP)
Evaluation is to strengthen and improve the capacity of SSPs to conduct
regular monitoring and evaluation to ensure that comprehensive
prevention services are provided to meet the needs of people who inject
drugs (PWID). The project will include SSPs that are listed in a
publicly available directory of all known SSPs in the United States
maintained by the North American Syringe Exchange Network (NASEN;
<a href="https://nasen.org">https://nasen.org</a>). SSPs will be sent a letter of invitation to
participate in a 35-minute program survey, called the Dave Purchase
Memorial Survey. Participating programs will have the option of
completing the survey via different modalities to enhance feasibility
and comfort in completing the survey, for example via the Research
Electronic Data Capture (REDCap) or a similarly secure web-based
application. Other modalities for survey administration will include a
coordinated telephone or videoconferencing interview.
The survey will include questions on operational characteristics
and services, client characteristics and drug use patterns, client
satisfaction, funding resources, community relations, and key
operational successes and challenges. Approximately 600 SSPs will be
able to participate in the survey. We anticipate that approximately 20%
of SSPs will decline to complete the survey, yielding approximately 480
completed surveys per year. However, given that this is the first
survey of SSPs funded by CDC during the COVID-19 pandemic, it makes it
challenging to predict response rates. We estimate that it will take 35
minutes to complete the survey, regardless of how the respondent
chooses to complete it (i.e., self-administered online or interviewer-
administered by phone or videoconferencing). SSPs that do not respond
to the initial survey invitation will be given reminders to complete
the survey over the duration of the survey implementation period. The
final reminder will include a link to a single question for SSPs that
choose not to complete the survey about why they declined to complete
the survey. Given the uncertainties in response rates described above,
we are requesting enough burden hours to allow at least 80% of SSPs to
respond to this question. We estimate that it will take two minutes to
respond to this question.
The total estimated annual burden hours are 296. There are no other
costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs................ Survey Y1 and Survey Y2- 480 1 35/60
3.
Non-responding SSPs................... Non-Response Survey Item 480 1 2/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-15226 Filed 7-16-21; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on July 19, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.